Ex vivo determination of opiate antagonist binding at μ-opioid ([3H]-Dago) receptors in hypothalamic micropunches from maturing female rats: Comparison between SDZ 210-096 and nalmefene

Bardo, 1983, Chronic naltrexone increases opiate binding in brain and produces supersensitivity to morphine in the locus coeruleus of the rat, Brain Res., 289, 223, 10.1016/0006-8993(83)90023-9 Dixon, 1984, Nalmefene: radioimmunoassay for a new opioid antagonist, J. Pharm. Sci., 73, 1645, 10.1002/jps.2600731141 Donham, 1986, Naloxone administration to female hamsters advances puberty by enhancing luteinizing hormone release, 182, 291 Evans, 1974, Degree and duration of reversal by naloxone of effects of morphine in conscious subjects, Br. Med. J., 2, 589, 10.1136/bmj.2.5919.589 Gabriel, 1983, Effects of a sustained-release naloxone pellet on luteinizing hormone secretion in female rats, Neuroendocrinology, 37, 342, 10.1159/000123573 Gai, 1986, Prolonged antagonism of opioid action with intravenous nalmefene in man, Anesthesiology, 64, 175, 10.1097/00000542-198602000-00008 Grossman, 1987, Clinical uses of opioid agonists and antagonists, 538 Hahn, 1975, Narcotic antagonists. 4. Carbon-6 derivatives of N-substituted noroxymorphones as narcotic antagonists, J. Med. Chem., 18, 259, 10.1021/jm00237a008 Landymore, 1990, Ontogenesis of cell surface μ-opioid ([3H]-DAGO) binding sites in rat hypothalamus and ex vivo determination of blood-brain barrier penetration by opioid peptide FK 33–824, Dev. Brain Res., 54, 169, 10.1016/0165-3806(90)90139-P Landymore, 1988, Influence of neonatal opioid blockade or injections of gonadotrophin-releasing hormone on the timing of puberty in female rats: correlation of opioid effects with occupation of hypothalamic μ-opioid receptors, J. Endocr., 119, 447, 10.1677/joe.0.1190447 Longnecker, 1973, Naloxone for antagonism of morphine-induced respiratory depression, Anesth. Analg., 52, 447, 10.1213/00000539-197352030-00033 McNicholas, 1984, New and experimental therapeutic roles for naloxone and related opioid antagonists, Drugs, 27, 81, 10.2165/00003495-198427010-00004 Meijs-Roelofs, 1989, Advancement of first ovulation by the opioid antagonist naltrexone, Biol. Reprod., 41, 842, 10.1095/biolreprod41.5.842 Meijs-Roelofs, 1988, Effects of treatment with the opioid antagonists naloxone and naltrexone on LH secretion and on sexual maturation in immature female rats, J. Endocr., 117, 237, 10.1677/joe.0.1170237 Meyerson, 1985, Neonatal exposure to naltrexone affects morphine sensitivity and facilitates sexual behaviour in female rats, Neurosci. Lett., 62, 323, 10.1016/0304-3940(85)90569-5 Mishra, 1980, Current status of preclinical research on disposition, pharmacokinetics, and metabolism of naltrexone, 132 Owens, 1981, Development of acute tolerance to the effects of naloxone on the hypothalamic-pituitary-luteinizing hormone axis in the male rat, J. Pharmacol. Exp. Ther., 216, 135 Siegel, 1989, Effects of the novel opiate antagonist, SDZ 210-096, on luteinizing hormone secretion in the rat, J. Pharmacol. Exp. Ther., 249, 264 Sirinathsinghji, 1985, Induction of precocious puberty in the female rat after chronic naloxone administration during the neonatal period: the opiate “brake” on prepubertal gonadotrophin secretion, J. Endocr., 104, 299, 10.1677/joe.0.1040299 Van Vugt, 1989, Comparison of the duration of action of nalmefene and naloxone on the hypothalamic-pituitary axis of the rhesus monkey, Neuroendocrinology, 49, 275, 10.1159/000125128 Vizi, 1976, The structure-action relationship and kinetics of some naloxone and naltrexone derivatives, Pharmacology, 14, 76, 10.1159/000136582 Wildt, 1987, Induction of ovulation by the chronic administration of naltrexone in hypothalamic amenorrhea, J. Clin. Endocrinol. Metab., 64, 1334, 10.1210/jcem-64-6-1334 Wilkinson, 1989, Do brain opioid peptides regulate the onset of puberty?, 70 Wilkinson, 1991, Opioid receptors in micropunches of fresh hypothalamic tissue: a binding assay for Everyman Zagon, 1984, Naltrexone modulates body and brain development in rats: a role for endogenous opioid systems in growth, Life Sci., 35, 2057, 10.1016/0024-3205(84)90563-0 Zivin, 1982, How to analyze binding, enzyme and uptake data: the simplest case, a single phase, Life Sci., 30, 1407, 10.1016/0024-3205(82)90554-9 Zukin, 1982, Naltrexone-induced opiate receptor supersensitivity, Brain Res., 245, 285, 10.1016/0006-8993(82)90811-3